pentamidine has been researched along with Pneumonia, Bacterial in 4 studies
Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.
Pneumonia, Bacterial: Inflammation of the lung parenchyma that is caused by bacterial infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, the impact of PCP prophylaxis on the incidence of bacterial pneumonia in HIV-positive patients using pentamidine or co-trimoxazole is still unknown." | 7.70 | [Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine]. ( Braun, J; Dalhoff, K; Friedrich, HJ; Kämmerer, R; Koch, A; Kothe, H, 1998) |
| " However, the impact of PCP prophylaxis on the incidence of bacterial pneumonia in HIV-positive patients using pentamidine or co-trimoxazole is still unknown." | 3.70 | [Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine]. ( Braun, J; Dalhoff, K; Friedrich, HJ; Kämmerer, R; Koch, A; Kothe, H, 1998) |
| "Pneumonia is an important cause of morbidity and mortality in the United States." | 2.39 | Prevention of community-acquired and nosocomial pneumonia. ( Santos, MR; Simberkoff, MS, 1996) |
| "Pulmonary nocardiosis should be considered as a differential diagnosis of recurring pneumonia in immunocompromised patients, especially in HIV-infected individuals." | 1.37 | Pulmonary nocardiosis caused by Nocardia exalbida complicating Pneumocystis pneumonia in an HIV-infected patient. ( Fujii, T; Gonoi, T; Imai, K; Iwamoto, A; Kikuchi, T; Koga, M; Koibuchi, T; Miura, T; Nakamura, H; Yazawa, K, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imai, K | 1 |
| Koibuchi, T | 1 |
| Kikuchi, T | 1 |
| Koga, M | 1 |
| Nakamura, H | 1 |
| Miura, T | 1 |
| Gonoi, T | 1 |
| Yazawa, K | 1 |
| Iwamoto, A | 1 |
| Fujii, T | 1 |
| Gracia, JD | 1 |
| Miravitlles, M | 1 |
| Mayordomo, C | 1 |
| Ferrer, A | 1 |
| Alvárez, A | 1 |
| Bravo, C | 1 |
| Vendrell, M | 1 |
| Simberkoff, MS | 1 |
| Santos, MR | 1 |
| Koch, A | 1 |
| Kothe, H | 1 |
| Braun, J | 1 |
| Kämmerer, R | 1 |
| Friedrich, HJ | 1 |
| Dalhoff, K | 1 |
1 review available for pentamidine and Pneumonia, Bacterial
| Article | Year |
|---|---|
Prevention of community-acquired and nosocomial pneumonia.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacterial Vaccines; Community-Acquired Infections; Cross I | 1996 |
3 other studies available for pentamidine and Pneumonia, Bacterial
| Article | Year |
|---|---|
Pulmonary nocardiosis caused by Nocardia exalbida complicating Pneumocystis pneumonia in an HIV-infected patient.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Fluoroquinolones; Humans; Male; Middle | 2011 |
Empiric treatments impair the diagnostic yield of BAL in HIV-positive patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifung | 1997 |
[Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; CD4 Lymphocy | 1998 |